Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1976 2
1977 1
1978 1
1979 1
1980 5
1981 2
1982 4
1983 3
1984 4
1985 5
1986 6
1987 8
1988 3
1989 2
1990 3
1991 5
1992 2
1993 4
1994 2
1995 4
1996 4
1997 3
1998 1
2000 5
2002 5
2003 6
2004 9
2005 9
2006 9
2007 9
2008 10
2009 14
2010 5
2011 8
2012 6
2013 11
2014 11
2015 12
2016 14
2017 12
2018 10
2019 5
2020 6
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Risperidone in children with autism and serious behavioral problems.
McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D; Research Units on Pediatric Psychopharmacology Autism Network. McCracken JT, et al. Among authors: aman mg. N Engl J Med. 2002 Aug 1;347(5):314-21. doi: 10.1056/NEJMoa013171. N Engl J Med. 2002. PMID: 12151468 Free article. Clinical Trial.
Beware of over-interpreting negative trials.
Scahill L, Aman MG, McCracken JT, McDougle CJ, Vitiello B. Scahill L, et al. Among authors: aman mg. J Autism Dev Disord. 2008 Oct;38(9):1609-10. doi: 10.1007/s10803-008-0581-7. Epub 2008 Jul 2. J Autism Dev Disord. 2008. PMID: 18594960 No abstract available.
Dr. Handen et al. Reply.
Handen BL, Veenstra-VanderWeele J, Anagnostou E, Aman MG. Handen BL, et al. Among authors: aman mg. J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):793-795. doi: 10.1016/j.jaac.2018.08.005. J Am Acad Child Adolesc Psychiatry. 2018. PMID: 30274655
Pharmacotherapy of disorders in mental retardation.
Aman MG, Collier-Crespin A, Lindsay RL. Aman MG, et al. Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I98-107. doi: 10.1007/s007870070023. Eur Child Adolesc Psychiatry. 2000. PMID: 11140785 Review.
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.
Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, Scahill L. Lecavalier L, et al. Among authors: aman mg. J Autism Dev Disord. 2014 May;44(5):1128-43. doi: 10.1007/s10803-013-1974-9. J Autism Dev Disord. 2014. PMID: 24158679 Free PMC article. Review.
A review of atomoxetine effects in young people with developmental disabilities.
Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. Aman MG, et al. Res Dev Disabil. 2014 Jun;35(6):1412-24. doi: 10.1016/j.ridd.2014.03.006. Epub 2014 Apr 16. Res Dev Disabil. 2014. PMID: 24732041 Free PMC article. Review.
231 results